Adaptive Elastomeric Microwell Platform for Live Cell Encapsulation

Encapsulation of live cells involves enclosing them within a semi-permeable barrier that protects against immune attack and mechanical stress while allowing the exchange of nutrients and signaling molecules. This approach is widely used in biomedical research, diagnostics, and cell therapy manufacturing. Conventional methods typically suspend cells in polymer solutions that are cross-linked into beads or gels, sometimes preceded by microwell aggregation. While established, these approaches often suffer from limited adaptability, inconsistent sample sizes, and labor-intensive retrieval processes.

This technology introduces an adaptive elastomeric microwell platform that enables adjustable dimensions and high-throughput encapsulation of biological samples. It can accommodate a wide range of sample sizes, from single cells to complex multicellular aggregates such as tumor spheroids and organoids. The platform supports physiologically relevant growth and proliferation, and importantly, allows encapsulated samples to be released intact without enzymatic or harsh mechanical disruption.

By combining flexibility, secure encapsulation, and gentle retrieval, this solution addresses a clear market need for customizable and cost-efficient live cell handling. It holds strong potential for research institutions and Institutes of Higher Learning engaged in cell biology, organoid research, and advanced drug screening; for pharmaceutical and biotechnology companies seeking scalable, contamination-free sample preparation for R&D and clinical use; and for clinical laboratories and hospitals requiring standardized, zero-loss handling of rare or patient-derived samples. In addition, laboratory equipment and consumables manufacturers may benefit from integrating this platform into existing product lines or automation systems, extending its impact across the broader life sciences and healthcare ecosystem.

This technology has broad applicability across pharmaceuticals, biotechnology, life sciences, clinical diagnostics, and research tool manufacturing. It is particularly valuable for organizations engaged in live cell handling, organoid development, precision medicine, and advanced drug screening.

Key applications include high-throughput drug uptake and penetration studies with controlled sample sizes; organoid and tumor spheroid culture for disease modeling and therapeutic testing; preservation and zero-loss handling of rare or patient-derived samples in both clinical and research workflows; and sample encapsulation for transport, enabling long-distance or cross-border delivery of live cells without cryopreservation. The platform also supports size-based sorting of cell aggregates to improve assay reproducibility, as well as personalized medicine workflows such as patient-specific testing and screening.

Potential marketable products include consumable elastomeric microwell plates with adjustable well sizes, modular encapsulation (release units compatible with automated liquid handling systems), and fully integrated sample preparation platforms for laboratory and clinical environments. These product formats allow seamless adoption into existing workflows, delivering scalable, contamination-free, and loss-preventing solutions for modern cell-based research and therapeutic applications.

This technology is the first elastomeric microwell platform to enable fully reversible sample encapsulation and release without chemical additives. Its purely mechanical operation integrates seamlessly into existing laboratory workflows, eliminating chemical exposure, reducing processing steps, and minimizing contamination risks.

Unlike conventional methods, the platform ensures zero sample loss, making it especially valuable for rare or low-quantity samples. It uniquely combines adjustable well dimensions, high-throughput capacity, and individual sample release within a single system.

By providing a three-dimensional microenvironment that reflects the natural scale of biological samples, the platform supports physiologically relevant growth of advanced models such as organoids and tumor spheroids. It delivers a versatile, contamination-free, and loss-preventing solution tailored to the needs of modern cell biology, pharmaceutical research, and clinical applications.